The sorbitol-negative strains were examined for resistance against ampicillin (10 µg), cephalothin (30 µg), ceftazidime (30 µg), gentamicin (10 µg), doxycycline (30 µg), ciprofloxacin (5 µg), nalidixic acid (30 µg), cotrimoxazole (25 µg), and chloramphenicol (30 µg) (MAST Group Ltd., UK), using Kirby-Bauer disc diffusion susceptibility test and the characterization of strains as susceptible, reduced susceptibility or resistant was as recommended by the Clinical and Laboratory Standards Institute (CLSI) (14 ).
Doxycycline
Manufactured by Mast Group
Sourced in United Kingdom
Doxycycline is a laboratory reagent used in various research and analytical applications. It is a tetracycline-class antibiotic that can be utilized for specific experimental purposes. The core function of Doxycycline is to serve as a chemical compound for research and analysis, without making any claims about its intended use.
Automatically generated - may contain errors
Lab products found in correlation
Co trimoxazole, by Mast Group (2 mentions)
Ceftazidime, by Mast Group (2 mentions)
Gentamicin, by Mast Group (2 mentions)
Ciprofloxacin, by Mast Group (2 mentions)
Chloramphenicol, by Mast Group (1 mentions)
Nalidixic acid, by Mast Group (1 mentions)
Ampicillin, by Mast Group (1 mentions)
Minocycline, by Mast Group (1 mentions)
Colistin sulfate salt powder, by Merck Group (1 mentions)
Piperacillin tazobactam, by Mast Group (1 mentions)
Ceftriaxone, by Mast Group (1 mentions)
Tetracycline, by Mast Group (1 mentions)
Meropenem, by Mast Group (1 mentions)
Tobramycin, by Mast Group (1 mentions)
Ampicillin sulbactam, by Mast Group (1 mentions)
Amikacin, by Mast Group (1 mentions)
Levofloxacin, by Mast Group (1 mentions)
Cefotaxime, by Mast Group (1 mentions)
Cefepime, by Mast Group (1 mentions)
Imipenem, by Mast Group (1 mentions)
2 protocols using doxycycline
1
Antibiotic Susceptibility of Sorbitol-Negative Strains
2
Antimicrobial Susceptibility Testing Protocol
Check if the same lab product or an alternative is used in the 5 most similar protocols
+ Expand
Antimicrobial susceptibility testing was carried out by the Kirby–Bauer disc diffusion method according to Clinical and Laboratory Standards Institute (CLSI) [12 ] and breakpoint interpretations for including amikacin (30 µg), gentamicin (10 µg), tobramycin (10 µg), cotrimoxazole (trimethoprim–sulfamethoxazole) (25 µg), tigecycline (15 µg), doxycycline (30 µg), tetracycline (30 µg), minocycline (30 µg) ceftriaxone (30 µg), ceftazidime (30 µg), cefepime (30 µg), cefotaxime (30 µg), piperacillin/tazobactam (100/10 µg), ampicillin-sulbactam (10/10 µg), imipenem (10 µg), meropenem (10 µg), ciprofloxacin (5 µg), levofloxacin (5 µg), (Mast Group Ltd., Bootle, UK). The minimum inhibitory concentrations (MICs) of colistin (Colistin sulfate salt powder, Sigma-Aldrich, St. Louis, MO, USA) were determined using the broth microdilution method according to CLSI guidelines (CLSI, 2020). Escherichia coli ATCC 25922 and Pseudomonas aeruginosa ATCC 27,853 strains were used as the standard strains.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!